Opdivo, simply nivolumab, represents a significant advancement in tumor treatment. It's a class of immunotherapy, specifically a monoclonal antibody, designed to stimulate your body's natural responses attack malignant cells. Unlike conventional treatments that kill cancer cells, Opdivo operates